Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02447120 · ClinicalTrials.gov registry record

Topcon 3D OCT-1 Maestro Reference Database Study II

A clinical trial of Healthy, sponsored by Topcon Medical Systems.

Completed
Registry status
504
Enrollment target
7
Study locations

NCT02447120: Completed study of Healthy, sponsored by Topcon Medical Systems.

NCT02447120 is a study of Healthy that has completed, run by Topcon Medical Systems. The registered enrollment target is 504 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (22% lower). The trial reports 7 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02447120, a study of Healthy, has completed, sponsored by Topcon Medical Systems.

COMPLETED
Registry status
504 participants
Enrollment target
7
Study locations

Study Summary

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.

Conditions Studied

Healthy

Interventions

  • DEVICE 3D OCT-1 Maestro

Study Locations (7)

California

  • Southern California College of Optometry - Fullerton
  • Valley Eyecare Center - Livermore
  • Western University of Health Sciences - Pomona

New York

  • New York VA - Jamaica
  • SUNY College of Optometry - New York

Alabama

  • UAB School of Optometry - Birmingham

Illinois

  • Illinois College of Optometry - Chicago

Trial Details

FieldValue
Enrollment Target 504 participants
Start Date 2015-05
Est. Completion 2015-10

Sponsor

Topcon Medical Systems

24 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02447120

The ClinicalTrials.gov registry entry for NCT02447120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 504 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (22% lower). The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which 3D OCT-1 Maestro is the first listed.

NCT02447120 reports 7 study locations spanning 4 distinct geographic areas - top geographies include California, New York, Alabama.

Frequently Asked Questions

What is clinical trial NCT02447120 about?

NCT02447120 is a clinical study titled "Topcon 3D OCT-1 Maestro Reference Database Study II". The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.

What is the current status of trial NCT02447120?

This trial is currently completed. The enrollment target is 504 participants. The study started on 2015-05. Estimated completion is 2015-10.

What conditions does trial NCT02447120 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02447120?

The interventions under investigation include: 3D OCT-1 Maestro (DEVICE).

Who is sponsoring clinical trial NCT02447120?

This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02447120 being conducted?

This trial has 7 study locations across Alabama, California, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.